摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

trans-bis(3-isopropyl-7-oxocyclohepta-1,3,5-trien-1-olato)palladium(II) | 1107602-82-3

中文名称
——
中文别名
——
英文名称
trans-bis(3-isopropyl-7-oxocyclohepta-1,3,5-trien-1-olato)palladium(II)
英文别名
[Pd(hinokitiol)2]
trans-bis(3-isopropyl-7-oxocyclohepta-1,3,5-trien-1-olato)palladium(II)化学式
CAS
1107602-82-3;148752-93-6
化学式
C20H22O4Pd
mdl
——
分子量
432.812
InChiKey
BRSQPTYRDLCQGZ-UHFFFAOYSA-L
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    None
  • 重原子数:
    None
  • 可旋转键数:
    None
  • 环数:
    None
  • sp3杂化的碳原子比例:
    None
  • 拓扑面积:
    None
  • 氢给体数:
    None
  • 氢受体数:
    None

反应信息

  • 作为反应物:
    描述:
    trans-bis(3-isopropyl-7-oxocyclohepta-1,3,5-trien-1-olato)palladium(II) 、 trans-bis(3-isopropyl-7-oxocyclohepta-1,3,5-trien-1-olato)copper(II) cis-bis(3-isopropyl-7-oxocyclohepta-1,3,5-trien-1-olato)copper(II) 以 乙醚 为溶剂, 生成 trans-bis(3-isopropyl-7-oxocyclohepta-1,3,5-trien-1-olato)copper(II) trans-bis(3-isopropyl-7-oxocyclohepta-1,3,5-trien-1-olato)palladium(II) 、 trans-bis(3-isopropyl-7-oxocyclohepta-1,3,5-trien-1-olato)copper(II) trans-bis(3-isopropyl-7-oxocyclohepta-1,3,5-trien-1-olato)palladium(II)
    参考文献:
    名称:
    具有(5/1)和(3/2)配方的反双(扁柏基)铜(II)反双(扁柏基)钯(II)共晶体
    摘要:
    反-双(3-异丙基-7-氧代环庚-1,3,5-三烯-1-醇)铜(II)反-双(3-异丙基-7-氧代环庚-1,3,5-三烯-1-酮(5/1)和(3/2)复合物[铜(C 10 H 11 O 2)2 ]·0.2 [Pd(C 10 H 11 O 2)2 ]和[Cu( C 10 H 11 O 2)2 ]·0.67 [Pd(C 10 H 11 O 2)2],其中3-异丙基-7-氧代环庚-1,3,5-三烯-1-油酸酯是扁桃酸酯阴离子(hino)的系统名称,是第一个从M x分离出的混合金属共结晶产物(日野)y配合物家族。这些共晶体包含具有晶体学反演对称性的方平面反式Cu(hino)2和反式Pd(hino)2分子。这些共晶化合物的整体配方为Cu 1- x Pd x(hino)2,其中x(5/1)乘积为0.166(4),(3/2)乘积为0.399(4)。大量制剂只是这些化合物中存在的全分子取代疾病的便捷平均表达。的中号-O键的范围是1
    DOI:
    10.1107/s0108270111007372
  • 作为产物:
    描述:
    potassium tetrachloropalladate(II) 、 [Na(hinokitiol)]*2H2O 以 为溶剂, 以74.9%的产率得到trans-bis(3-isopropyl-7-oxocyclohepta-1,3,5-trien-1-olato)palladium(II)
    参考文献:
    名称:
    Syntheses, structures and antimicrobial activities of various metal complexes of hinokitiol
    摘要:
    Metal-oxygen bonding complexes (M = Mg-II, Mn-II, Ni-II, Mo-VI, W-VI, Pd-II, Sb-III, Bi-III, Fe-III, Ti-IV, K-I, Ba-II, Zr-IV and Hf-IV) with a hinokitiol (Hhino; 2-hydroxy-4-isopropylcyclohepta-2,4,6-trienone or beta-thujaplicin) ligand, which has two unequivalent oxygen donor atoms, were synthesized and characterized by elemental analysis, TG/DTA, FT-IR and solution (H-1 and C-13) NMR spectroscopy. Single-crystal X-ray structure analysis revealed various molecular structures for the complexes, which were classified into several families of family, i.e. type A [M-II(hino)(2)(L)](2) (M = Mg-II, Mn-II, Ni-II; L = EtOH or MeOH), with a dimeric structure consisting of one bridging hino anion, one chelating hino anion and one alcohol or water molecule, type B, with the octahedral, cis-dioxo, bis-chelate complexes cis-[(MO2)-O-VI(hino)(2)] (M= Mo-VI, W-VI), type C, with square planar complex [M-II(hino)(2)] (M= Pd-II), type D, with tris-chelate, 7-coordinate complexes with one inert electron pair [M-III(hino)(3)] (M= Sb-III, Bi-III), type D', with the bis-chelate, pseudo-6-coordinate complexes with one inert electron pair [M-III(hino)(2)X] (M = Sb-III, X = Br), type E, with tris-chelate, 6-coordinate complexes with Delta and Lambda isomers [M-III(hino)(3)] (M= Fe-III), type E' of bis-chelate, 6-coordinate complex [M-IV(hino)(2)X-2] (M = Ti-IV, X = Cl), type F, with water-soluble alkali metal salts [M-I(hino)] (M = K-I), and type H, with tetrakis-chelate, 8-coordinate complexes [M-IV(hino)(4)](M = Zr-IV, Hf-IV). These structural features were compared with those of metal complexes with a related ligand, tropolone (Htrop). The antimicrobial activities of these complexes, evaluated in terms of minimum inhibitory concentration (MIC; mu g mL(-1)) in two systems, were compared to elucidate the relationship between structure and antimicrobial activity. (c) 2008 Elsevier B.V. All rights reserved.
    DOI:
    10.1016/j.ica.2008.02.061
点击查看最新优质反应信息

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫